Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Table 4 Hematological parameters before and after salvage PRRT

	Baseline (mean ± SD)	n=	After Salvage PRRT	Difference (%)	p-value (paired t-test)
WBC (10³/μl)	6.62 ± 2.14	34	5.08 ± 2.01	−23.3	= 0.001
Erythrocytes (10⁶/μl)	4.49 ± 0.64	34	3.89 ± 0.70	−13.4	< 0.001
HB (g/dl)	13.44 ± 2.06	34	12.30 ± 2.06	−8.5	= 0.21
PLT count (10³/μl)	258.62 ± 109.94	34	200.71 ± 93.761	−22.4	= 0.016

ISSN: 1471-2407